Sleep quality in people with HIV disease.
This study examined sleep quality in HIV infected people. The research explored the incidence of the study variables (sleep quality, anxiety, well-being, and symptom severity) and found differences on the variables between subjects who reported HIV infection through male/male sex (n = 18) as compared to injecting drug use (n = 23). The instruments were the Pittsburgh Sleep Quality Index (PSQI), the HIV Assessment Tool (HAT), and the Spielberger State/Trait Anxiety Tool. The average subject (N = 56) was male, 48 years old, a person of color and reported HIV infection through injecting drug use. General well-being was significantly correlated (Pearson product moment correlations) with sleep quality (r = .46, p = .01). Significant differences on the global PSQI (t = 3.22, p = .003) and on the well-being factor of HAT (t = -2.05, p = .04) were found in that injecting drug users reported worse sleep quality and well-being. No significant differences were determined between the two groups on any of the other study variables.
Nokes
K M
KM
CUNY, Hunter College, Hunter-Bellevue School of Nursing, New York, USA.
Kendrew
J
J
D000328:Adult; D000368:Aged; D001007:Anxiety; D005260:Female; D015658:HIV Infections / Q000150:complications / Q000503:physiopathology* / Q000523:psychology; D006801:Humans; D017567:Karnofsky Performance Status; D008297:Male; D008875:Middle Aged; D012890:Sleep; D012893:Sleep Wake Disorders / Q000145:classification / Q000209:etiology; D011795:Surveys and Questionnaires